Prevention of Hepatocellular Carcinoma Development Associated with Chronic Hepatitis by Anti-Fas Ligand Antibody Therapy

A persistent immune response to hepatitis viruses is a well-recognized risk factor for hepatocellular carcinoma. However, the molecular and cellular basis for the procarcinogenic potential of the immune response is not well defined. Here, using a unique animal model of chronic hepatitis that induces...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Nakamoto, Yasunari, Kaneko, Shuichi, Fan, Hong, Momoi, Takashi, Tsutsui, Hiroko, Nakanishi, Kenji, Kobayashi, Kenichi, Suda, Takashi
Médium: Artigo
Jazyk:Inglês
Vydáno: The Rockefeller University Press 2002
Témata:
Brief Definitive Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2194047/
https://ncbi.nlm.nih.gov/pubmed/12391022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20020633
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky